✦ LIBER ✦

ADJUVANT THERAPY WITH BICALUTAMIDE 150 MG VERSUS STANDARD CARE ALONE: THIRD ANALYSIS RESULTS FROM TRIAL 24 OF THE EARLY PROSTATE CANCER PROGRAMME

✍ Scribed by M. Wirth; C. Tyrrell; K. Delaere; M. Sanchez-Chapado; J. Ramon; D. Wallace; J. Hetherington; F. Pina; C. Heyns; T. Borchers; S. Navani; J. Armstrong

Book ID: 119617147
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 70 KB
Volume: 5
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(06)60918-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bicalutamide (‘Casodex’) 150 mg as

Bicalutamide (‘Casodex’) 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme

✍ Chris J. Tyrrell; Heather Payne; William A. See; David G. McLeod; Manfred P. Wir 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 245 KB

A Randomised Comparison of Bicalutamide

A Randomised Comparison of Bicalutamide (‘Casodex’) 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer: First Report from the Scandinavian Prostatic Cancer Group Study No. 6

✍ P Iversen; T.L.J Tammela; S Vaage; O Lukkarinen; P Lodding; T Bull-Njaa; J Viita 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Bicalutamide as Immediate Therapy Either

Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program

✍ See, William A.; Wirth, Manfred P.; McLeod, David G.; Iversen, Peter; Klimberg, 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 461 KB

BICALUTAMIDE (150 MG) VERSUS PLACEBO AS

BICALUTAMIDE (150 MG) VERSUS PLACEBO AS IMMEDIATE THERAPY ALONE OR AS ADJUVANT TO THERAPY WITH CURATIVE INTENT FOR EARLY NONMETASTATIC PROSTATE CANCER: 5.3-YEAR MEDIAN FOLLOWUP FROM THE SCANDINAVIAN PROSTATE CANCER GROUP STUDY NUMBER 6

✍ IVERSEN, PETER; JOHANSSON, JAN-ERIK; LODDING, PÄR; LUKKARINEN, OLAVI; LUNDMO, PE 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 334 KB

BICALUTAMIDE 150 MG IN ADDITION TO STAND

BICALUTAMIDE 150 MG IN ADDITION TO STANDARD CARE IN PATIENTS WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE SECOND ANALYSIS OF THE EARLY PROSTATE CANCER PROGRAM AT MEDIAN FOLLOWUP OF 5.4 YEARS

✍ WIRTH, MANFRED P.; SEE, WILLIAM A.; McLEOD, DAVID G.; IVERSEN, PETER; MORRIS, TO 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 220 KB

Bicalutamide as immediate therapy either

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. See WA, Wirth MP, McLeod DG, Iversen P, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DM, Delaere KP, Vaage S, Tammela TL, Lukkarinen O, Persson BE, Carroll K, Kolvenbag GJ; Casodex Early Prostate Cancer Trialist Group, Medical College of Wisconsin, Milwaukee, WI: J Urol 2002;168:429–435

✍ Donald L Trump 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 23 KB